Cargando…

Adipose Tissue Wasting as a Determinant of Pancreatic Cancer-Related Cachexia

SIMPLE SUMMARY: Pancreatic cancer (PC) is one of the deadliest cancers in the US. The poor prognosis of PC is related to diagnostic delay and the presence of unintended weight loss (cachexia) that commonly presents in PC patients even before diagnosis. However, the current understanding of how PC me...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Seok-Yeong, Luan, Yi, Dong, Rosemary, Abazarikia, Amirhossein, Kim, So-Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563866/
https://www.ncbi.nlm.nih.gov/pubmed/36230682
http://dx.doi.org/10.3390/cancers14194754
_version_ 1784808503724998656
author Yu, Seok-Yeong
Luan, Yi
Dong, Rosemary
Abazarikia, Amirhossein
Kim, So-Youn
author_facet Yu, Seok-Yeong
Luan, Yi
Dong, Rosemary
Abazarikia, Amirhossein
Kim, So-Youn
author_sort Yu, Seok-Yeong
collection PubMed
description SIMPLE SUMMARY: Pancreatic cancer (PC) is one of the deadliest cancers in the US. The poor prognosis of PC is related to diagnostic delay and the presence of unintended weight loss (cachexia) that commonly presents in PC patients even before diagnosis. However, the current understanding of how PC mediates cachexia is limited, and there are few treatments clinically available for cachexia. Based on the current literature, we demonstrate that PC-related cachexia primarily results from the wasting of adipose tissue, once thought to be merely a storage depot but now appreciated as an instrumental metabolic organ in the body. In addition, poor survival in PC patients was found to be associated with adipose tissue loss at diagnosis and during treatment. Therefore, identifying potential mediators and molecular mechanisms underlying adipose tissue loss would promise to pave the way for the development of effective interventions for PC-related cachexia ABSTRACT: Pancreatic cancer (PC) is the third leading cause of cancer-related death in the US, and its 5-year survival rate is approximately 10%. The low survival rates largely stem from diagnostic delay and the presence of significant adipose tissue and muscle wasting, commonly referred to as cachexia. Cachexia is present in nearly 80% of PC patients and is a key cause of poor response to treatment and about 20% of death in PC patients. However, there are few clinical interventions proven to be effective against PC-related cachexia. Different cancer types feature distinct secretome profiles and functional characteristics which would lead to cachexia development differently. Therefore, here we discuss affected tissues and potential mechanisms leading to cachexia in PC. We postulate that the most affected tissue during the development of PC-related cachexia is adipose tissue, historically and still thought to be just an inert repository for excess energy in relation to cancer-related cachexia. Adipose tissue loss is considerably greater than muscle loss in quantity and shows a correlation with poor survival in PC patients. Moreover, we suggest that PC mediates adipose atrophy by accelerating adipocyte lipid turnover and fibroblast infiltration.
format Online
Article
Text
id pubmed-9563866
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95638662022-10-15 Adipose Tissue Wasting as a Determinant of Pancreatic Cancer-Related Cachexia Yu, Seok-Yeong Luan, Yi Dong, Rosemary Abazarikia, Amirhossein Kim, So-Youn Cancers (Basel) Review SIMPLE SUMMARY: Pancreatic cancer (PC) is one of the deadliest cancers in the US. The poor prognosis of PC is related to diagnostic delay and the presence of unintended weight loss (cachexia) that commonly presents in PC patients even before diagnosis. However, the current understanding of how PC mediates cachexia is limited, and there are few treatments clinically available for cachexia. Based on the current literature, we demonstrate that PC-related cachexia primarily results from the wasting of adipose tissue, once thought to be merely a storage depot but now appreciated as an instrumental metabolic organ in the body. In addition, poor survival in PC patients was found to be associated with adipose tissue loss at diagnosis and during treatment. Therefore, identifying potential mediators and molecular mechanisms underlying adipose tissue loss would promise to pave the way for the development of effective interventions for PC-related cachexia ABSTRACT: Pancreatic cancer (PC) is the third leading cause of cancer-related death in the US, and its 5-year survival rate is approximately 10%. The low survival rates largely stem from diagnostic delay and the presence of significant adipose tissue and muscle wasting, commonly referred to as cachexia. Cachexia is present in nearly 80% of PC patients and is a key cause of poor response to treatment and about 20% of death in PC patients. However, there are few clinical interventions proven to be effective against PC-related cachexia. Different cancer types feature distinct secretome profiles and functional characteristics which would lead to cachexia development differently. Therefore, here we discuss affected tissues and potential mechanisms leading to cachexia in PC. We postulate that the most affected tissue during the development of PC-related cachexia is adipose tissue, historically and still thought to be just an inert repository for excess energy in relation to cancer-related cachexia. Adipose tissue loss is considerably greater than muscle loss in quantity and shows a correlation with poor survival in PC patients. Moreover, we suggest that PC mediates adipose atrophy by accelerating adipocyte lipid turnover and fibroblast infiltration. MDPI 2022-09-29 /pmc/articles/PMC9563866/ /pubmed/36230682 http://dx.doi.org/10.3390/cancers14194754 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yu, Seok-Yeong
Luan, Yi
Dong, Rosemary
Abazarikia, Amirhossein
Kim, So-Youn
Adipose Tissue Wasting as a Determinant of Pancreatic Cancer-Related Cachexia
title Adipose Tissue Wasting as a Determinant of Pancreatic Cancer-Related Cachexia
title_full Adipose Tissue Wasting as a Determinant of Pancreatic Cancer-Related Cachexia
title_fullStr Adipose Tissue Wasting as a Determinant of Pancreatic Cancer-Related Cachexia
title_full_unstemmed Adipose Tissue Wasting as a Determinant of Pancreatic Cancer-Related Cachexia
title_short Adipose Tissue Wasting as a Determinant of Pancreatic Cancer-Related Cachexia
title_sort adipose tissue wasting as a determinant of pancreatic cancer-related cachexia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563866/
https://www.ncbi.nlm.nih.gov/pubmed/36230682
http://dx.doi.org/10.3390/cancers14194754
work_keys_str_mv AT yuseokyeong adiposetissuewastingasadeterminantofpancreaticcancerrelatedcachexia
AT luanyi adiposetissuewastingasadeterminantofpancreaticcancerrelatedcachexia
AT dongrosemary adiposetissuewastingasadeterminantofpancreaticcancerrelatedcachexia
AT abazarikiaamirhossein adiposetissuewastingasadeterminantofpancreaticcancerrelatedcachexia
AT kimsoyoun adiposetissuewastingasadeterminantofpancreaticcancerrelatedcachexia